Hospitalist Doctors in Elmira, NY Accepting Medicare

7 Hospitalist doctors found. Showing 1 - 7

Emmanuel Oponde Misodi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7770    Fax: 607-271-3686

Miss Janet M Maltez, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 602 Ivy St, Elmira, NY 14905 Phone: 607-735-4633    Fax: 607-735-4628

Dr. Manav Bandlamudi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Ivy St, Elmira, NY 14905 Phone: 607-737-8157

Dr. Ranjan V Kumar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7770    Fax: 607-271-3686

Dr. Charles Junior Badger Ii, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7770    Fax: 607-271-3686

Dr. William George Newman, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7770    Fax: 607-271-3686

Dr. Vidhya A Reddy, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-7771    Fax: 607-271-3686

News Archive

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.

Key molecule can be used to assess prognosis of triple negative breast cancer

Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

Researchers discover CTE in deceased patient's brain with no known history of head trauma

Researchers at Toronto Western Hospital's Canadian Concussion Centre have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.

Study pinpoints potential transmission advantage of SARS-CoV-2 variant B.1.1.7

Researchers in the UK have shown that the increased transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.7 that emerged in the UK during the coronavirus disease 2019 (COVID-19) pandemic does not appear to be the result of increased viral replication or immune escape.

FDA proposes rule to allow use of alternative temperature devices for food processing

The Food and Drug Administration (FDA) has issued a proposed rule which, if finalized, would benefit both consumers and the food industry by enabling manufacturers of heat-processed low-acid canned foods to modernize their equipment by using alternative temperature-indicating devices (TIDs).

Read more Medical News

› Verified 8 days ago